Larvol Delta - Rituximab-for-PTLD-Prevention-in-Solid-Organ-Transplant-Recipients-With-EBV-DNAemia

Rituxan (rituximab) - Roche

http://clinicaltrials.gov/ct2/show/NCT07614282

Sep 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next